This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Technische Unversität Berlin. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Franziska Wanka: Innovator in Microbial Metabolite Production
Introduction
Franziska Wanka is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of microbial biotechnology, particularly in the production of chimeric cyclooligodepsipeptides. Her innovative work has implications for various applications in pharmaceuticals and biotechnology.
Latest Patents
Franziska Wanka holds a patent titled "Process for producing chimeric cyclooligodepsipeptides in filamentous fungi." This patent describes a method for obtaining at least one microbial secondary metabolite or a derivative thereof. The method includes the step of heterologous expression of at least one synthetase of the secondary metabolite in at least one filamentous fungus. The patent also discloses an expression cassette, a plasmid vector including the expression cassette, an expression host, cyclodepsipeptides, and a chimeric cyclodepsipeptide synthetase. She has 1 patent to her name.
Career Highlights
Franziska Wanka is affiliated with Technische Universität Berlin, where she conducts her research and development activities. Her work at the university has positioned her as a key figure in the field of microbial metabolite production.
Collaborations
Some of her notable coworkers include Simon Boecker and Dirk Storm. Their collaborative efforts contribute to advancing research in microbial biotechnology.
Conclusion
Franziska Wanka's innovative work in the production of chimeric cyclooligodepsipeptides showcases her expertise and commitment to advancing the field of biotechnology. Her contributions are paving the way for future developments in microbial metabolite applications.